Skip to Main Content

In awarding the Nobel Prize in chemistry to scientists who had developed a new way of seeing the structure of biomolecules, the Nobel committee this week noted that the technology is more than a tool for basic research. It’s also “decisive…for the development of pharmaceuticals,” the committee said.

Biopharma companies absolutely agree.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!